Abstract
Objective: We aimed to develop clinical classifiers to identify prevalent ascending aortic dilatation in patients with BAV and tricuspid aortic valve (TAV). Methods: This study included BAV (n=543) and TAV (n=491) patients with aortic valve disease and/or ascending aortic dilatation but devoid of coronary artery disease undergoing cardiothoracic surgery. We applied machine learning algorithms and classic logistic regression models, using multiple variable selection methodologies to identify predictors of high risk of ascending aortic dilatation (ascending aorta with a diameter above 40 mm). Analyses included comprehensive multidimensional data (i.e., valve morphology, clinical data, family history of cardiovascular diseases, prevalent diseases, demographic, lifestyle and medication). Results: BAV patients were younger (60.4±12.4 years) than TAV patients (70.4±9.1 years), and had a higher frequency of aortic dilatation (45.3% vs. 28.9% for BAV and TAV, respectively. P<0.001). The aneurysm prediction models showed mean AUC values above 0.8 for TAV patients, with the absence of aortic stenosis being the main predictor, followed by diabetes and high sensitivity C-Reactive Protein. Using the same clinical measures in BAV patients our prediction model resulted in AUC values between 0.5-0.55, not useful for prediction of aortic dilatation. The classification results were consistent for all machine learning algorithms and classic logistic regression models. Conclusions: Cardiovascular risk profiles appear to be more predictive of aortopathy in TAV patients than in patients with BAV. This adds evidence to the fact that BAV- and TAV-associated aortopathy involve different pathways to aneurysm formation and highlights the need for specific aneurysm preventions in these patients. Further, our results highlight that machine learning approaches do not outperform classical prediction methods in addressing complex interactions and non-linear relations between variables.